Bioenergetic Analysis of Ovarian Cancer Cell Lines: Profiling of Histological Subtypes and Identification of a Mitochondria-Defective Cell Line

New perspectives on molecular targeted therapy in ovarian clear cell carcinoma

(2013) D S P Tan et al.   BRITISH JOURNAL OF CANCER

Metabolic changes during ovarian cancer progression as targets for sphingosine treatment

(2013) Angela S. Anderson et al.   EXPERIMENTAL CELL RESEARCH

The role of dynamin-related protein 1 in cancer growth: a promising therapeutic target?

(2013) Wei Qian et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

The Effects of Metformin on Ovarian Cancer

(2013) Piyemeth Dilokthornsakul et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Cyclin-dependent kinases regulate splice-specific targeting of dynamin-related protein 1 to microtubules

(2013) Stefan Strack et al.   JOURNAL OF CELL BIOLOGY

Careful Selection of Reference Genes Is Required for Reliable Performance of RT-qPCR in Human Normal and Cancer Cell Lines

(2013) Francis Jacob et al.   PLoS One

Integrative Bioinformatics Links HNF1B with Clear Cell Carcinoma and Tumor-Associated Thrombosis

(2013) Justin Cuff et al.   PLoS One

Evaluating cell lines as tumour models by comparison of genomic profiles

(2013) Silvia Domcke et al.   Nature Communications

New Hypothesis on Pathogenesis of Ovarian Cancer Lead to Future Tailored Approaches

(2013) P. Rescigno et al.   Biomed Research International

Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer

(2012) Jalees Rehman et al.   FASEB JOURNAL

Protein profiles in human ovarian cancer cell lines correspond to their metabolic activity and to metabolic profiles of respective tumor xenografts

(2012) Christian Fabian et al.   FEBS Journal

BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery

(2012) J Hagenbuchner et al.   ONCOGENE

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.

(2012) Ethan Cerami et al.   Cancer Discovery

Prognostic Value of Preoperative Metabolic Tumor Volume and Total Lesion Glycolysis in Patients with Epithelial Ovarian Cancer

(2011) Hyun Hoon Chung et al.   ANNALS OF SURGICAL ONCOLOGY

Ovarian clear cell carcinoma as a stress-responsive cancer: Influence of the microenvironment on the carcinogenesis and cancer phenotype

(2011) Masaki Mandai et al.   CANCER LETTERS

Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer

(2011) P. A. Konstantinopoulos et al.   CANCER RESEARCH

Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas

(2011) David S.P. Tan et al.   CLINICAL CANCER RESEARCH

The association between endometriosis and ovarian cancer: A review of histological, genetic and molecular alterations

(2011) Peter Svenssen Munksgaard et al.   GYNECOLOGIC ONCOLOGY

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm

(2011) Robert J. Kurman et al.   HUMAN PATHOLOGY

Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers

(2011) Michael P. Stany et al.   PLoS One

Membrane Remodeling Induced by the Dynamin-Related Protein Drp1 Stimulates Bax Oligomerization

(2010) Sylvie Montessuit et al.   CELL

Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and reactive oxygen species

(2010) Brian P. Dranka et al.   FREE RADICAL BIOLOGY AND MEDICINE

Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary

(2010) Ahmed Ashour Ahmed et al.   JOURNAL OF PATHOLOGY

ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas

(2010) Kimberly C. Wiegand et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes

(2010) K Yamaguchi et al.   ONCOGENE

Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma

(2010) Siân Jones et al.   SCIENCE

Glutamine addiction: a new therapeutic target in cancer

(2010) David R. Wise et al.   TRENDS IN BIOCHEMICAL SCIENCES

Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma

(2009) Kuan-Ting Kuo et al.   AMERICAN JOURNAL OF PATHOLOGY

CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers

(2009) Chunqiao Tian et al.   CANCER

Mitochondrial reactive oxygen species regulate hypoxic signaling

(2009) Robert B Hamanaka et al.   CURRENT OPINION IN CELL BIOLOGY

Drp1 levels constitutively regulate mitochondrial dynamics and cell survival in cortical neurons

(2009) Takuma Uo et al.   EXPERIMENTAL NEUROLOGY

Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner

(2009) R. Rattan et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative Stress

(2008) K. Yamaguchi et al.   CLINICAL CANCER RESEARCH

Preoperative evaluation of pelvic masses with combined18F-fluorodeoxyglucose positron emission tomography and computed tomography

(2008) Yorito Yamamoto et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α

(2008) Jordi Rius et al.   NATURE

Mitochondria and cellular oxygen sensing in the HIF pathway

(2007) Cormac T. Taylor   BIOCHEMICAL JOURNAL